Question · asked by 1 review
Summary of findings table ‐ Rifampin/rifampicin vs placebo: Risk for at least one adverse event per patient
- Population
- participants with cholestatic pruritus (CP)
- Intervention
- Summary of findings table ‐ Rifampin/rifampicin
- Comparison
- placebo
- Outcome
- Risk for at least one adverse event per patient
It is very uncertain whether summary of findings table ‐ Rifampin/rifampicin changes risk for at least one adverse event per patient compared with placebo (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Summary of findings table ‐ Rifampin/rifampicin vs placebo Risk for at least one adverse event per patient · patients with cholestatic pruritus (CP) It is very uncertain whether summary of findings table ‐ Rifampin/rifampicin changes risk for at least one adverse event per patient compared with placebo (very low certainty). Pharmacological interventions for pruritus in adult palliative care patients (2024) · Cochrane Headline outcomes only | RR 0.29 [0.03, 2.51] | 1 study · 39 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.